“Ophthalmic Drugs Contract Manufacturing Market, 2020-2030” {Roots Analysis}

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:

Type of product

Ophthalmic APIOphthalmic drug FDFType of FDF manufacturedSolidSemi-solidLiquid / suspension

Type of primary packaging

Ampoule / vial 

Glass / plastic bottle

Ointment tube

Blister packing

Other forms

Scale of manufacturing

ClinicalCommercial

Company size

SmallMid-sizedLargeVery large

Target disease indication

Age-related macular degenerationDry eyeGlaucomaOther disease segments

Key geographical regions

North America (US, Canada and Mexico)Europe (UK, Germany, France, Spain, Italy and rest of Europe)Asia-Pacific (India, China, Japan, Australia and rest of Asia-Pacific)Rest of the world

To request a sample copy / brochure, please visit this - https://www.rootsanalysis.com/reports/294/request-sample.html

Key Questions Answered

What is the clinical research landscape of investigational ophthalmic drugs?What percentage of ophthalmic drug manufacturing operations are outsourced to service providers?What are the preferred primary packaging formats / fill finish containers of ophthalmic drugs?Who are the leading contract manufacturers of ophthalmic APIs and drug FDFs, across the globe?What are the key challenges faced by ophthalmic drug contract manufacturers?What is the annual, clinical and commercial demand for ophthalmic drugs?What is the current, installed manufacturing capacity for ophthalmic drugs?What are the anticipated future trends related to ophthalmic drug manufacturing?How is the current and future market opportunity likely to be distributed across key market segments?

You may also be interested in the following titles:

China Biopharmaceutical Contract Manufacturing Market, 2020-2030Pharmaceutical Continuous Manufacturing Market, 2020-2030Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030

Contact:

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

[email protected]